The document discusses the human gut microbiome and its relationship to health and disease. It references studies showing that the gut microbiome can influence obesity, metabolic disorders, and inflammatory diseases. Probiotics, prebiotics, and genetically engineered bacteria are mentioned as potential therapies for manipulating the gut microbiome to treat various conditions like inflammatory bowel disease.

1. ŁOWCY MIKROBÓW 2008 w poszukiwaniu teorii wszystkiego Wojciech Marlicz Klinika Gastroenterologii PAM, Szczecin Kongres PTG-E Gdańsk 13-15 czerwiec 2008

2. „ The dependence of the intestinal microbes on the food makes it possible to adopt measures to modify the flora in our bodies and to replace the harmful microbes by useful microbes.” 1. Mietchnikoff E. The prolongation of life. Optimistic studies. London: Butterworth Heinemann, 1907 2. Pasteur L. et al.: Summary report of the experiments conducted at Pouilly-le-Fort, near Melun, on the anthrax vaccination, 1881.

3. 1. Guamer F. et al.: Mechanism of Disease: the hygiene hypothesis revisited. Nature Clinical Practice Gastroenterology & Hepatology. 2006; 3, 275-284 2. Weiss ST. : Eat dirt – the hygiene hypothesis and allergic diseases. N Engl J Med. 2002,19; 47(12):930-1

4. Jama ustna Żołądek Dwunastnica Jelito czcze Jelito kręte Jelito grube Odbyt Lactobacilli 1-100/g Lactobacilli 1x10 2 /g Streptococci 1x10 4 /g Lactobacilli Streptococci Enterobacteria Bifidobacteria Yeasts 1x10 5 /g 1x10 6 /g Bifidobacteria Lactobacilli Streptococci Bacteroides Enterobacteria 1x10 5 /g 1x10 8 /g Bacteroides Eubacteria Bifidobacteria Anaerobic cocci Clostridia Lactobacilli Enterobacteria Streptococci 1x10 10 /g 1x10 11 /g

5. Gill SR et al.: Metagenomics analysis of the human distal gut microbiome. Science, 2006; 312 (5728):1355-1359

7. Madara J. N Engl J Med 2004;351:1685-1686 Tickling Toll-like Receptors (TLRs)

8. Guarnerl F et al. (2006) Mechanisms of Disease: the hygiene hypothesis revisited Nat Clin Pract Gastroenterol Hepatol 3: 275 – 284 doi:10.1038/ncpgasthep0471 Decision-making in the adaptive immune system is modulated by innate costimulatory signals

9. Wilson I.: Top-down versus bottom-up rediscovering physiology via Systems biology? Molecular Systems Biology, 2007, May, 3, 113

10. Ley RE et al.: Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444 (7122): 1022-1023 Turnbaugh PJ et al.: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 2006, 444; 21; 6-9

11. Siebler J. et al.: The gut-liver-axis: Endotoxemia, inflammation, insulin resistance and NASH. J Hepatology, 2008; 48, 1030-1034 Thalheimer U et al.: Infection, coagulation and variceal bleeding in cirrhosis. GUT, 2005; 54; 556-563

12. Rescigno M et al.: The Pathogenic Role of Intestinal Flora in IBD and Colon Cancer. Current Drug Targets, 2008, 9, 395-403

13. Scanian PD et al.: Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environmental Microbiology. 2008, 10 (3), 789-798 Hope ME et al.: Sporadic colorectal cancer – role of the commensal microbiota. FEMS Microbiology Letters. 2005; 244; 1-7

14. Amaral FA et al.: Commensal microbiota is fundamental for the development of inflammatory pain. PNAS, 2008, Vol 105, 6; 2193 Tjellstrom B et al.: Gut microflora Associated Characteristics in Children with Celiac Disease. Am J Gastroenterology, 2005; 100: 2784-2788

17. Bjerrum JT et al. (2008) Technology Insight: metabonomics in gastroenterology—basic principles and potential clinical applications Nat Clin Pract Gastroenterol Hepatol doi:10.1038/ncpgasthep1125 The relationship between the different 'omics' and their interaction via defined biologic processes

18. Metabonomika - to nowa dziedzina zajmująca się całościową oceną dynamicznych zmian metabolicznych zachodzących w organizmach żywych. Marchesi JR et al.: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 2007; 6: 546-551 Saric J et al.: Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J Proteome Res 2008; 7: 352-360

19. O’Hara AM et al.: The gut flora as a forgotten organ. EMBO 2006, vol 7, 7, 688

20. Mikroflora jelitowa + + + + Farmabiotyki Jia W., Zhao L., Nicholson JK.: Gut microbiota: a potential new territory for drug targeting. Nature Review, Vol 7; Feb 2008 Inne mikroorganizmy Prebiotyki Antybiotyki Probiotyki TURBO Leki stabilizujące błonę komórkową (leki izopatycze?) Fragmenty DNA LPS

23. Corr S.C. et al.: Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC188. PNAS, 2007, vol 104; 18, 2617-2621 Farmabiotyki TURBO Probiotyki

24. Sleator and Hill: Designer probiotics: a potential therapeutic for Clostridium difficile ? J Med Microbiol. 2008; 57: 793-794 TURBO Probiotyki Lactococcus lactis Thy 12 Steidler et al.: Treatment of murine colitis by Lactococcus lactis Secreting interleukin-10. Science 2000; 289 (5483):1352-5 Vandenbroucke K et al.: Active delivery of trefoil factors by genetically modified Lactoccus lactis prevents and heals acute colitis in mice. Gastroenterology 204; 127(2):502-13 Braat H et al.: A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease. Clin Gastroenterol Hepatol 2006; 4(6):754-9